Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
March 27 2025 - 6:17PM
Edgar (US Regulatory)
EXHIBIT 99.1
JOINT FILING AGREEMENT
We, the undersigned, hereby express our agreement that the Schedule 13D (or any amendments thereto) relating to the common stock of Syros Pharmaceuticals, Inc. is filed on behalf of each of us.
Dated: March 27, 2025
Samsara BioCapital, L.P.
By:
Samsara BioCapital GP, LLC
its
General Partner
By:
/s/ Srinivas Akkaraju
Name: Srinivas Akkaraju
Title: Managing Member
Samsara BioCapital GP, LLC
By:
/s/ Srinivas Akkaraju
Name: Srinivas Akkaraju
Title: Managing Member
/s/ Srinivas Akkaraju
Srinivas Akkaraju
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Jun 2025 to Jul 2025
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Jul 2024 to Jul 2025
